Mirabella Financial Services LLP Bio Atla, Inc. Transaction History

Mirabella Financial Services LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$6.29 - $11.01 $75,756 - $132,604	12,044 New	12,044 $99,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $5.38 $31,737 - $80,162	-14,900 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$4.38 - $18.78 $65,262 - $279,822	14,900 New	14,900 $74,000
Q1 2021 May 17, 2021	SELL	$32.41 - $70.91 $317,617 - $694,918	-9,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.02 - $35.16 $303,996 - $344,567	9,800 New	9,800 $333,000

17.4M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $16.3M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.